Paul Stockdale has been appointed chief financial officer at Oxford BioDynamics Plc, effective 15 September. A chartered accountant, he is joining the UK biotechnology company from e-Therapeutics Plc where he has been financial controller. Oxford BioDynamics is developing epigenetic biomarkers of disease.
Mr Stockdale holds a master’s degree in natural science from the University of Cambridge in the UK.
Oxford BioDynamics announced the appointment on 30 June 2017.
Copyright 2017 Evernow Publishing Ltd